Covered recipient · General Payments record
RODNEY D GIN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$6,314.24
- Reported across 265 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $765.96 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $429.13 | 12 |
| GENZYME CORPORATION | $183.15 | 7 |
| Biofrontera Inc. | $57.06 | 3 |
| REVANCE THERAPEUTICS, INC. | $40.72 | 2 |
| Incyte Corporation | $28.57 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $27.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.66 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800014 | CMS |
| ABBVIE INC. | $29.76 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800016 | CMS |
| ABBVIE INC. | $31.74 | 03/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800018 | CMS |
| ABBVIE INC. | $26.49 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800020 | CMS |
| ABBVIE INC. | $32.74 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800022 | CMS |
| ABBVIE INC. | $24.15 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800024 | CMS |
| ABBVIE INC. | $28.77 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800026 | CMS |
| ABBVIE INC. | $29.92 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800028 | CMS |
| ABBVIE INC. | $23.07 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800030 | CMS |
| ABBVIE INC. | $143.21 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800032 | CMS |
| ABBVIE INC. | $1.94 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800034 | CMS |
| ABBVIE INC. | $28.68 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103800036 | CMS |
| Biofrontera Inc. | $11.18 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092759751 | CMS |
| Biofrontera Inc. | $20.99 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1095484760 | CMS |
| Biofrontera Inc. | $24.89 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1102949653 | CMS |
| GENZYME CORPORATION | $23.26 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139694978 | CMS |
| GENZYME CORPORATION | $27.14 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139694996 | CMS |
| GENZYME CORPORATION | $27.62 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139695002 | CMS |
| GENZYME CORPORATION | $31.45 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139695000 | CMS |
| GENZYME CORPORATION | $21.21 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139695016 | CMS |
| GENZYME CORPORATION | $29.37 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139695044 | CMS |
| GENZYME CORPORATION | $23.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139695074 | CMS |
| Incyte Corporation | $28.57 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141241694 | CMS |
| REVANCE THERAPEUTICS, INC. | $19.83 | 01/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918766 | CMS |
| REVANCE THERAPEUTICS, INC. | $20.89 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147918768 | CMS |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $27.33 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152196817 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.